Physix Frontier
2026 humanoid robot IPO wave: Over 20 core firms racing for listings
The 2026 "Humanoid Robot" IPO Wave: Over 20 Core Companies Racing for Listings
2026 is defined by the industry as the inaugural year for mass production and capitalization of Chinese humanoid robots. Driven by four core factors—policy deregulation, implementation of ten-thousand-unit scale production, concentrated release of exit demands from the primary market, and global valuation resonance—a large number of humanoid robot OEMs and upstream component companies are simultaneously flooding into the A-share STAR Market, ChiNext, and the HKEX Chapter 18C Special Purpose Technology channel.
As of July 2026, over 20 core domestic companies have entered the IPO tutoring, filing, hearing, or issuance stages. The capital market has become the core engine driving industrial expansion and technological iteration. The industry has officially moved from the "concept R&D phase" to a new stage of scaled commercial implementation plus capital market pricing.
Four Core Catalysts
1. Top-Level Policy Endorsement
Humanoid robots and embodied intelligence were included in the annual Government Work Report, positioning them as a core track for new quality productive forces. The expansion of the STAR Market's Fifth Set of Standards accommodates robotics companies that are heavy on early-stage R&D but not yet profitable.
2. Mass Production Validation
2026 officially enters the ten-thousand-unit mass production cycle. Tesla's Optimus production line retrofit is complete, with a weekly production target of one thousand units in H2 2026; domestic players Unitree, Agibot, and UBTECH have all achieved order deliveries at the thousand/ten-thousand unit level.
3. Capitalization System Deregulation
The expansion of the STAR Market's Fifth Set of Standards and the continued relaxation of listing thresholds via the HKEX Chapter 18C channel for hard tech. Unitree's rapid approval and registration clearance serve as landmark cases of policy tilt.
4. Global Valuation Resonance
Global humanoid robot targets are being chased by capital markets, creating a valuation benchmarking effect.
